GENEVA, Oct. 5 -- OLIO LABS INCORPORATED filed a patent application (US2026/020534) for “COMBINATION OF GLP-1 RECEPTOR AGONIST, MC4R AGONIST, AND HCAR2 AGONIST FOR USE IN WEIGHT LOSS”. With publication no. WO/2026/206942, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 38/26
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....